NYSE:NVO

Novo Nordisk A/S SEC Filings & 10K Form

$111.64

+0.21 (+0.19%)

(As of 07/1/2022 05:44 PM ET)

Add

Compare

Today's Range: $108.71
▼
$111.85
50-Day Range: $103.24
▼
$115.96
52-Week Range: $83.86
▼
$122.16

Volume: 934,548 shs
Average Volume: 1.50 million shs
Market Capitalization: $262.89 billion

P/E Ratio: 33.23
Dividend Yield: 1.33%
Price Target: $682.43

Recent Novo Nordisk A/S SEC Filings

Filing Types

Ownership Filings

Export to Excel

Date	Filer	Form Type
06/27/2022 7:55 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/21/2022 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/13/2022 8:26 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/13/2022 8:25 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/07/2022 7:41 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/03/2022 5:56 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/31/2022 8:07 AM	Novo Nordisk A/S (Filer)	Form SD Specialized Disclosure Report
05/31/2022 6:06 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/24/2022 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/24/2022 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

05/24/2022 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/23/2022 9:15 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/06/2022 4:20 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/04/2022 5:02 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/04/2022 5:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/04/2022 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/03/2022 1:53 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/03/2022 7:42 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/03/2022 5:02 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/03/2022 5:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/03/2022 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/29/2022 6:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/28/2022 10:51 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/27/2022 9:24 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/27/2022 9:23 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/25/2022 9:30 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/20/2021 5:59 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/13/2021 8:26 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/07/2021 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/30/2021 6:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/30/2021 6:01 AM	Novo Nordisk A/S (Filer) Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/23/2021 5:34 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/16/2021 8:59 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/11/2021 9:02 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/04/2021 11:36 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/04/2021 5:34 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/26/2021 6:58 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/19/2021 6:52 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/12/2021 8:19 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/06/2021 5:10 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/29/2021 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/22/2021 8:20 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/14/2021 9:55 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/07/2021 9:22 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/07/2021 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/01/2021 5:10 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/27/2021 9:46 AM	Novo Nordisk A/S (Filer)	Form SD Specialized Disclosure Report
05/18/2021 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/10/2021 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/10/2021 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/10/2021 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/05/2021 5:36 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/04/2021 10:42 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/29/2021 6:17 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/27/2021 9:48 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/27/2021 9:31 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/26/2021 6:53 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/21/2021 10:11 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/19/2021 6:48 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/12/2021 1:47 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/29/2021 7:33 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/25/2021 11:51 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/25/2021 11:50 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/22/2021 11:09 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/15/2021 9:20 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/08/2021 6:57 AM	Novo Nordisk A/S (Filer) Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/01/2021 12:20 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/23/2021 5:10 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/22/2021 8:21 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/17/2021 6:20 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/17/2021 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/08/2021 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/03/2021 1:36 PM	Novo Nordisk A/S (Filer)	Form IRANNOTICE
02/03/2021 1:34 PM	Novo Nordisk A/S (Filer)	Form 20-F Registration statement / Annual report / Transition report
02/03/2021 1:06 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/03/2021 1:01 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/03/2021 5:35 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/02/2021 9:23 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/26/2021 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/21/2021 5:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/11/2021 7:10 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/29/2020 7:17 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/22/2020 7:14 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/18/2020 5:12 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/16/2020 9:57 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/14/2020 3:57 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/07/2020 9:12 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/04/2020 7:22 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/30/2020 10:17 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/18/2020 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/17/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/09/2020 7:17 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/09/2020 6:08 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/05/2020 8:49 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/04/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/04/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/04/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/30/2020 8:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/29/2020 7:27 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/26/2020 9:38 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

This page (NYSE:NVO) was last updated on 7/2/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Just $1.00 for your first month.

Novo Nordisk A/S SEC Filings & 10K Form

Recent Novo Nordisk A/S SEC Filings

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources